- Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illnessG G Nomikos
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285 0510, USA
Behav Brain Res 113:97-103. 2000..These results may also contribute to unraveling the cellular basis of nicotine's association with neuropsychiatric disorders, thereby offering the prospect of new therapeutic advances for their treatment...
- A role for cannabinoid CB1 receptors in mood and anxiety disordersJ M Witkin
Psychiatric Drug Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 0510, USA
Behav Pharmacol 16:315-31. 2005....
- The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamusE T Tzavara
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285-0510, USA
Eur J Pharmacol 426:R3-4. 2001..This increase in norepinephrine outflow could play an important role in the pharmacological and potentially therapeutic actions of SR141716A...
- Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the ratR J Davis
Mol Psychiatry 13:240-1. 2008